Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention.
Chikata Y, Iwata H, Miyosawa K, Naito R, Koike T, Moriya S, Yasuda H, Funamizu T, Doi S, Endo H, Wada H, Ogita M, Dohi T, Kasai T, Isoda K, Okazaki S, Miyauchi K, Minamino T. Chikata Y, et al. Cardiovasc Diabetol. 2024 Mar 30;23(1):114. doi: 10.1186/s12933-024-02197-z. Cardiovasc Diabetol. 2024. PMID: 38555431 Free PMC article.
Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
Funamizu T, Iwata H, Nishida Y, Miyosawa K, Doi S, Chikata Y, Shitara J, Endo H, Wada H, Naito R, Ogita M, Dohi T, Kasai T, Okazaki S, Isoda K, Miyauchi K, Daida H. Funamizu T, et al. Among authors: chikata y. Cardiovasc Diabetol. 2020 Feb 18;19(1):21. doi: 10.1186/s12933-020-00996-8. Cardiovasc Diabetol. 2020. PMID: 32070335 Free PMC article.
Long-term impact of high-sensitivity C-reactive protein in patients with intermittent claudication due to peripheral artery disease following endovascular treatment.
Fukase T, Dohi T, Kato Y, Chikata Y, Takahashi N, Endo H, Doi S, Nishiyama H, Okai I, Iwata H, Okazaki S, Isoda K, Miyauchi K, Daida H, Minamino T. Fukase T, et al. Among authors: chikata y. Heart Vessels. 2021 Nov;36(11):1670-1678. doi: 10.1007/s00380-021-01863-6. Epub 2021 May 6. Heart Vessels. 2021. PMID: 33956183
Serum apolipoprotein E levels predict residual cardiovascular risk in patients with chronic coronary syndrome undergoing first percutaneous coronary intervention and on-statin treatment.
Fukase T, Dohi T, Chikata Y, Takahashi N, Endo H, Doi S, Nishiyama H, Kato Y, Okai I, Iwata H, Okazaki S, Isoda K, Miyauchi K, Daida H, Minamino T. Fukase T, et al. Among authors: chikata y. Atherosclerosis. 2021 Sep;333:9-15. doi: 10.1016/j.atherosclerosis.2021.08.021. Epub 2021 Aug 12. Atherosclerosis. 2021. PMID: 34418683
Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
Fukase T, Dohi T, Koike T, Yasuda H, Takeuchi M, Takahashi N, Chikata Y, Endo H, Doi S, Nishiyama H, Okai I, Iwata H, Okazaki S, Miyauchi K, Daida H, Minamino T. Fukase T, et al. Among authors: chikata y. ESC Heart Fail. 2022 Feb;9(1):545-554. doi: 10.1002/ehf2.13715. Epub 2021 Nov 22. ESC Heart Fail. 2022. PMID: 34811932 Free PMC article.
Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axis.
Chikata Y, Iwata H, Miyosawa K, Koike T, Yasuda H, Funamizu T, Doi S, Endo H, Wada H, Naito R, Ogita M, Dohi T, Kasai T, Isoda K, Okazaki S, Miyauchi K, Minamino T. Chikata Y, et al. Sci Rep. 2022 Mar 24;12(1):5129. doi: 10.1038/s41598-022-09059-2. Sci Rep. 2022. PMID: 35332212 Free PMC article.
Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following percutaneous coronary intervention: A 10-year follow-up study.
Nishiyama H, Funamizu T, Iwata H, Endo H, Chikata Y, Doi S, Wada H, Naito R, Ogita M, Kato Y, Okai I, Dohi T, Kasai T, Isoda K, Okazaki S, Miyauchi K, Minamino T. Nishiyama H, et al. Among authors: chikata y. Int J Cancer. 2022 Nov 1;151(9):1482-1490. doi: 10.1002/ijc.34164. Epub 2022 Jul 7. Int J Cancer. 2022. PMID: 35796324 Free PMC article.
Paradoxical Long-Term Impact Between Serum Apolipoprotein E and High-Density Lipoprotein Cholesterol in Patients Undergoing Percutaneous Coronary Intervention.
Fukase T, Dohi T, Nishio R, Takeuchi M, Takahashi N, Chikata Y, Endo H, Doi S, Nishiyama H, Okai I, Iwata H, Okazaki S, Miyauchi K, Daida H, Minamino T. Fukase T, et al. Among authors: chikata y. J Atheroscler Thromb. 2023 Jun 1;30(6):611-623. doi: 10.5551/jat.63535. Epub 2022 Aug 5. J Atheroscler Thromb. 2023. PMID: 35934781 Free PMC article.
Combined impacts of low apolipoprotein A-I levels and reduced renal function on long-term prognosis in patients with coronary artery disease undergoing percutaneous coronary intervention.
Fukase T, Dohi T, Nishio R, Takeuchi M, Takahashi N, Chikata Y, Endo H, Doi S, Nishiyama H, Okai I, Iwata H, Okazaki S, Miyauchi K, Daida H, Minamino T. Fukase T, et al. Among authors: chikata y. Clin Chim Acta. 2022 Nov 1;536:180-190. doi: 10.1016/j.cca.2022.09.020. Epub 2022 Oct 4. Clin Chim Acta. 2022. PMID: 36202225
41 results